Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: data from the ICONA cohort

Delayed presentation of HIV among older individuals: a growing problem

(2022) Amy C Justice et al.   Lancet HIV

The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis

(2022) Negin Farhadian et al.   Substance Abuse: Treatment, Prevention, and Policy

Treatment failure, death, and predictors among PLWHIV on second-line antiretroviral therapy in Dessie Comprehensive Specialized Hospital, northeast Ethiopia: A retrospective cohort study

(2022) Shambel Wedajo et al.   PLoS One

Re‐assessing the late HIV diagnosis surveillance definition in the era of increased and frequent testing

(2022) Peter D. Kirwan et al.   HIV MEDICINE

Determinants of HIV-1 late presentation in a cohort of Portuguese HIV-1 patients

(2021) Ana Cláudia Miranda et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy

(2021) Roberta Gagliardini et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Overall tolerability of Integrase Inhibitors in clinical practice: results from a multicenter Italian cohort

(2020) Arturo Ciccullo et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV

(2020) Mohamed N’dongo Sangaré et al.   MEDICINE

Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

(2019) Annalisa Mondi et al.   Journal of the International AIDS Society

Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study

(2019) Marc-Antoine Valantin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Is the rate of virological failure to cART continuing to decline in recent calendar years?

(2019) Stefano Rusconi et al.   JOURNAL OF CLINICAL VIROLOGY

Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data

(2018) Amedeo Ferdinando Capetti et al.   ANNALS OF PHARMACOTHERAPY

Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting

(2018) Antonella d’Arminio Monforte et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact study

(2017) Giovanni Guaraldi et al.   AIDS Research and Therapy

Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection

(2016) Denise C. Hsu et al.   DRUGS

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice

(2016) Antonio Di Biagio et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004–2013

(2016) Paz Sobrino-Vegas et al.   JOURNAL OF INFECTION

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy

(2016) Adam Trickey et al.   PLoS One

Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART

(2015) Giuseppe Lapadula et al.   PLoS One

Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation

(2013) C. Laprise et al.   CLINICAL INFECTIOUS DISEASES

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

(2013) Amanda Mocroft et al.   PLOS MEDICINE

Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings

(2012) Olawale Ajose et al.   AIDS

Risk Factors for Hospitalization and Medical Intensive Care Unit (MICU) Admission Among HIV-Infected Veterans

(2012) Kathleen M. Akgün et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Predictive Accuracy of the Veterans Aging Cohort Study Index for Mortality With HIV Infection

(2012) Amy C. Justice et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort

(2011) Steven F.L. van Lelyveld et al.   AIDS

Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome

(2011) Antonella d’Arminio Monforte et al.   ANTIVIRAL THERAPY

Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters

(2010) L Waters et al.   HIV MEDICINE

Late presentation of HIV infection: a consensus definition

(2010) A Antinori et al.   HIV MEDICINE

Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

(2010) Amanda Mocroft et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

A CD4+ Cell Count

(2010) Mona R Loutfy et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Treatment Failure and Mortality Factors in Patients Receiving Second-Line HIV Therapy in Resource-Limited Countries

(2010) Mar Pujades-Rodríguez   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study

(2008)   JOURNAL OF INFECTIOUS DISEASES